Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype.

about

Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype.

Item

http://www.wikidata.org/entity/Q54981975

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype.

@en

Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype.

@nl

type

Item

label

Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype.

@en

Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype.

@nl

prefLabel

Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype.

@en

Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype.

@nl

P1476

Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype

@en

P2093

Anne Walter

http://www.w3.org/2001/XMLSchema#string

Apirat Chaikuad

http://www.w3.org/2001/XMLSchema#string

Ingo Ott

http://www.w3.org/2001/XMLSchema#string

Laurent Meijer

http://www.w3.org/2001/XMLSchema#string

Lutz Preu

http://www.w3.org/2001/XMLSchema#string

Nadège Loaëc

http://www.w3.org/2001/XMLSchema#string

Renate Helmer

http://www.w3.org/2001/XMLSchema#string

Stefan Knapp

http://www.w3.org/2001/XMLSchema#string

P2860

The Protein Data Bank

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

MolProbity: all-atom structure validation for macromolecular crystallography

Human SPF45, a splicing factor, has limited expression in normal tissues, is overexpressed in many tumors, and can confer a multidrug-resistant phenotype to cells

DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome

Inhibitor binding to active and inactive CDK2: the crystal structure of CDK2-cyclin A/indirubin-5-sulphonate

Kinase Domain Insertions Define Distinct Roles of CLK Kinases in SR Protein Phosphorylation

Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A

Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing

Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co-crystal structure

P304

e0196761

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0196761

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Conrad Kunick

P577

2018-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29723265

http://www.w3.org/2001/XMLSchema#string

P932

5933782

http://www.w3.org/2001/XMLSchema#string